Dysplasia in Barrett's esophagus
- PMID: 4044629
- PMCID: PMC12253103
- DOI: 10.1007/BF00402729
Dysplasia in Barrett's esophagus
Abstract
In a retrospective histological study, resected specimens obtained from 23 patients with adenocarcinoma in Barrett's esophagus (Group I) and endoscopic multiple (step) biopsies from 38 patients without carcinoma in Barrett's esophagus (Group II) were investigated for dysplastic changes. Dysplasia was most frequently found in the type of mucosa comprising intestinal metaplasia. There seem to be two pathways to dysplasia in Barrett's esophagus. In Group I dysplasia was found in 18 out of 23, and in Group II in 2 out of 38 patients. In Barrett's esophagus, dysplasia may be considered not only a precursor of carcinoma, but also a marker for coexisting carcinoma.
References
-
- Belladonna JA, Hajdu SI, Bains MS, Winawer SJ (1974) Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology. N Engl J Med 291:895–896 - PubMed
-
- Berenson MM, Riddell RH, Skinner DB, Freston JW (1978) Malignant transformation of esophageal columnar epithelium. Cancer 41:554–561 - PubMed
-
- Blackstone MO, Riddell RH, Rogers BHG, Levin B (1981) Dysplasia-associated lesion or mass (DALM) detected by colonos-copy in long-standing ulcerative colitis: An indicator for colectomy. Gastroenterology 80:366–374 - PubMed
-
- Cuello C, Correa P, Zamara G, Lopez J, Murray J, Gordillo G (1979) Histopathology of gastric dysplasias. Am J Surg Pathol 3:491–500 - PubMed
-
- Geboes K, Vanstapel MJ, Desmet VJ, Vantrappen G (1981) Tissue demonstration of carcinoembryonic antigen (CEA) in columnar esophageal epithelium. Hepatogastroenterology 28:324–326 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical